824 related articles for article (PubMed ID: 19084273)
1. Adherence with topical glaucoma medication monitored electronically the Travatan Dosing Aid study.
Okeke CO; Quigley HA; Jampel HD; Ying GS; Plyler RJ; Jiang Y; Friedman DS
Ophthalmology; 2009 Feb; 116(2):191-9. PubMed ID: 19084273
[TBL] [Abstract][Full Text] [Related]
2. Risk factors for poor adherence to eyedrops in electronically monitored patients with glaucoma.
Friedman DS; Okeke CO; Jampel HD; Ying GS; Plyler RJ; Jiang Y; Quigley HA
Ophthalmology; 2009 Jun; 116(6):1097-105. PubMed ID: 19376591
[TBL] [Abstract][Full Text] [Related]
3. Patients' and physicians' perceptions of the travoprost dosing aid: an open-label, multicenter study of adherence with prostaglandin analogue therapy for open-angle glaucoma or ocular hypertension.
Flowers B; Wand M; Piltz-Seymour J; Berke SJ; Day D; Teague J; Smoot TM; Landry TA; Bergamini MV; Mallick S;
Clin Ther; 2006 Nov; 28(11):1803-11. PubMed ID: 17213000
[TBL] [Abstract][Full Text] [Related]
4. Monitoring adherence rates in glaucoma patients using the Travatan Dosing Aid. A 6-month study comparing patients on travoprost 0.004% and patients on travoprost 0.004%/timolol 0.5% fixed combination.
Rossi GC; Pasinetti GM; Scudeller L; Tinelli C; Milano G; Bianchi PE
Expert Opin Pharmacother; 2010 Mar; 11(4):499-504. PubMed ID: 20163264
[TBL] [Abstract][Full Text] [Related]
5. Adherence in glaucoma: objective measurements of once-daily and adjunctive medication use.
Robin AL; Novack GD; Covert DW; Crockett RS; Marcic TS
Am J Ophthalmol; 2007 Oct; 144(4):533-40. PubMed ID: 17686450
[TBL] [Abstract][Full Text] [Related]
6. Measurement of adherence to brimonidine therapy for glaucoma using electronic monitoring.
Hermann MM; Bron AM; Creuzot-Garcher CP; Diestelhorst M
J Glaucoma; 2011 Oct; 20(8):502-8. PubMed ID: 20852438
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of practice patterns for the care of open-angle glaucoma compared with claims data: the Glaucoma Adherence and Persistency Study.
Quigley HA; Friedman DS; Hahn SR
Ophthalmology; 2007 Sep; 114(9):1599-606. PubMed ID: 17572498
[TBL] [Abstract][Full Text] [Related]
8. Interventions improve poor adherence with once daily glaucoma medications in electronically monitored patients.
Okeke CO; Quigley HA; Jampel HD; Ying GS; Plyler RJ; Jiang Y; Friedman DS
Ophthalmology; 2009 Dec; 116(12):2286-93. PubMed ID: 19815286
[TBL] [Abstract][Full Text] [Related]
9. Adherence with brimonidine in patients with glaucoma aware and not aware of electronic monitoring.
Hermann MM; Papaconstantinou D; Muether PS; Georgopoulos G; Diestelhorst M
Acta Ophthalmol; 2011 Jun; 89(4):e300-5. PubMed ID: 21106046
[TBL] [Abstract][Full Text] [Related]
10. Personality traits, depression, and objectively measured adherence to once-daily prostaglandin analog medication in glaucoma.
Holló G; Kóthy P; Géczy A; Vargha P
J Glaucoma; 2009; 18(4):288-92. PubMed ID: 19365193
[TBL] [Abstract][Full Text] [Related]
11. Persistence and adherence with topical glaucoma therapy.
Nordstrom BL; Friedman DS; Mozaffari E; Quigley HA; Walker AM
Am J Ophthalmol; 2005 Oct; 140(4):598-606. PubMed ID: 16226511
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the role of travoprost 0.004% ophthalmic solution in the management of open angle glaucoma and ocular hypertensive patients.
Chiselită D;
Oftalmologia; 2007; 51(2):81-6. PubMed ID: 17937041
[TBL] [Abstract][Full Text] [Related]
13. Patterns and rate of adherence to glaucoma therapy using an electronic dosing aid.
Ajit RR; Fenerty CH; Henson DB
Eye (Lond); 2010 Aug; 24(8):1338-43. PubMed ID: 20339390
[TBL] [Abstract][Full Text] [Related]
14. Duration of IOP reduction with travoprost BAK-free solution.
Gross RL; Peace JH; Smith SE; Walters TR; Dubiner HB; Weiss MJ; Ochsner KI
J Glaucoma; 2008; 17(3):217-22. PubMed ID: 18414108
[TBL] [Abstract][Full Text] [Related]
15. Influence of switching to travoprost on intraocular pressure of uncontrolled chronic open-angle glaucoma patients compliant to previously-used topical medication.
Holló G; Vargha P; Kóthy P
Curr Med Res Opin; 2005 Dec; 21(12):1943-8. PubMed ID: 16368044
[TBL] [Abstract][Full Text] [Related]
16. The TRAVATAN Dosing Aid accurately records when drops are taken.
Friedman DS; Jampel HD; Congdon NG; Miller R; Quigley HA
Am J Ophthalmol; 2007 Apr; 143(4):699-701. PubMed ID: 17386285
[TBL] [Abstract][Full Text] [Related]
17. Adherence improvement in Dutch glaucoma patients: a randomized controlled trial.
Beckers HJ; Webers CA; Busch MJ; Brink HM; Colen TP; Schouten JS;
Acta Ophthalmol; 2013 Nov; 91(7):610-8. PubMed ID: 23025424
[TBL] [Abstract][Full Text] [Related]
18. Morning dosing of once-daily glaucoma medication is more convenient and may lead to greater adherence than evening dosing.
Ford BA; Gooi M; Carlsson A; Crichton AC
J Glaucoma; 2013 Jan; 22(1):1-4. PubMed ID: 21946541
[TBL] [Abstract][Full Text] [Related]
19. Determinants of medication adherence to topical glaucoma therapy.
Dreer LE; Girkin C; Mansberger SL
J Glaucoma; 2012; 21(4):234-40. PubMed ID: 21623223
[TBL] [Abstract][Full Text] [Related]
20. Brimonidine tartrate 0.15%, dorzolamide hydrochloride 2%, and brinzolamide 1% compared as adjunctive therapy to prostaglandin analogs.
Bournias TE; Lai J
Ophthalmology; 2009 Sep; 116(9):1719-24. PubMed ID: 19592108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
